D2C7-IT + 2141-V11 Combination Post-resection in rGBM

Clinical trial NCT06455605 · RECRUITING

Trial details

NCT number: NCT06455605
Sponsor: Darell Bigner
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Glioblastoma IDH Wildtype

Start date: 2025-03-17
Primary completion: 2029-01-31
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.